Related Experiment Videos
Coagulation studies in children and young adults with cerebral ischemic episodes
Insights
This study investigated pathogenic factors in young patients experiencing cerebral ischemia. A significant finding was impaired vessel wall fibrinolysis in many patients, suggesting a potential treatment target for cerebral thrombosis.
Area of Science:
- Neurology
- Hematology
- Vascular Medicine
Background:
- Cerebral ischemia affects individuals under 45, with various predisposing factors identified.
- Understanding the etiology of cerebral ischemia in younger populations is crucial for effective management.
Purpose of the Study:
- To retrospectively analyze pathogenic factors contributing to cerebral ischemia in patients under 45.
- To explore potential links between coagulation abnormalities and cerebral thrombosis in this demographic.
Main Methods:
- Retrospective study of 101 patients under 45 with objective signs of cerebral ischemia.
- Analysis of predisposing factors, including medical history, trauma, and contraceptive pill use.
- Evaluation of coagulation parameters, focusing on fibrinolysis.
Main Results:
- Predisposing factors were present in 41 patients.
- Abnormal coagulation values were found in 64 patients.
- Deficient vessel wall fibrinolysis was the most frequent abnormality, observed in 38% of patients.
Conclusions:
- Impaired vessel wall fibrinolysis is a notable finding in young patients with cerebral thrombosis.
- Further investigation into the fibrinolytic system is warranted for potential therapeutic interventions.
- Specific fibrinolytic stimulating agents may offer a treatment avenue for cerebral thrombosis.
Abstract:
One hundred and one patients below 45 years and showing objective signs of cerebral ischemia were studied retrospectively for pathogenic factors. Twelve were below 15 years; the male to female ratio was 1:1. Factors known as predisposing (heart disease, hypertension, hyperlipemia, diabetes mellitus or infectious diseases) and other possible factors (e.g. trauma, abuse) were found in 41 patients. Among women using contraceptive pills there might be an increased risk of development of cerebral thrombosis, but the material was not large enough to warrant statistical analysis. In 64 patients one or more abnormal coagulation values were found, the most frequent being a deficient vessel wall fibrinolysis, which was noted in 38%. We therefore consider it worthwhile to investigate the fibrinolytic defence mechanism of the vessel wall in patients with cerebral thrombosis, since it is possible to treat this condition with specific fibrinolytic stimulating agents.